slides · global inventory
Complication
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 25,056
Current window 17,041-17,070
Pages 836
Rows per page 30
Beat
17,041-17,070 of 25,056
05
The slide is split into two columns: 'Battery systems and vehicle integration' and 'Outlook'. The latter includes a standard forward-looking statement disclaimer.Hexagon Purus | Results Presentation Deck | 23 slides · Hexagon Purus
Conference presentation Investor relations Beat · NeedLoop · Voice Of Customer1 hit
03
The slide uses a circular central graphic to anchor the list of pain points.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Includes both qualitative business milestones and quantitative financial results/guidance.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
The slide uses a three-row structure to categorize company assets and relationships.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
The slide uses a process-like flow to connect technical features to quantitative performance outcomes.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Early Struggles1 hit
07
The slide uses a horizontal timeline to track progress against specific technical and production milestones.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Early Struggles1 hit
03
The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
04
The slide uses a wave-like visual to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The slide uses a stylized area chart to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem & Complication1 hit
06
The table uses a standard pharmaceutical pipeline layout with clinical and preclinical segments.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem & Complication1 hit
07
The slide uses a hub-and-spoke diagram to illustrate the negative consequences of neurotoxicity.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
04
The slide uses a wave-like visual to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
05
The slide highlights NXC-201's superior efficacy (100% response rate) and safety profile (zero neurotoxicity) compared to existing therapies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
06
The slide explicitly notes that these are cross-trial comparisons and not head-to-head studies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a table structure to contrast standard of care with the company's target segment. The bottom section uses bar charts to imply relative patient population growth.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
08
The slide explicitly warns about cross-trial comparison limitations in the footer.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
09
The slide uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative outcomes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Innoviz | Results Presentation Deck | 18 slidesInnoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · NeedLoop · Why Now1 hit
05
Includes a direct quote from Nicolai Martin (BMW) regarding the strategic importance of LiDAR for Level 3 automation.Innoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · NeedLoop · Why Now1 hit
02
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Interest1 hit
03
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Interest1 hit
04
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
05
The slide uses a causal-chain/before-after-bridge hybrid structure to link specific problems to specific solutions.jetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
07
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Need1 hit
04
TPD = Targeted Protein Degradation. The slide uses a four-column layout to structure the company's value proposition.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
05
TPD stands for Targeted Protein Degradation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
06
The slide uses a dot-matrix representation to indicate therapeutic focus areas for specific drug candidates.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
07
The slide uses a Gantt-chart style layout to show the progression of various drug programs.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit